Articles

An increase in MYC copy number has a progressive negative prognostic impact in patients with diffuse large B-cell and high-grade lymphoma, who may benefit from intensified treatment regimens

Department of Hematology, ASST Spedali Civili di Brescia
Department of Molecular and Translational Medicine, Section of Pathology, University of Brescia, Brescia, Italy
Department of Molecular and Translational Medicine, Section of Pathology, University of Brescia, Brescia, Italy
Department of Hematology, ASST Spedali Civili di Brescia
Department of Hematology, ASST Spedali Civili di Brescia
Department of Hematology, ASST Spedali Civili di Brescia
Department of Molecular and Translational Medicine, Section of Pathology, University of Brescia, Brescia, Italy
Department of Hematology, ASST Spedali Civili di Brescia
Department of Hematology, ASST Spedali Civili di Brescia
Department of Hematology, ASST Spedali Civili di Brescia
Department of Hematology, ASST Spedali Civili di Brescia
Department of Hematology, ASST Spedali Civili di Brescia
Department of Molecular and Translational Medicine, Section of Pathology, University of Brescia, Brescia, Italy
Department of Molecular and Translational Medicine, Section of Pathology, University of Brescia, Brescia, Italy
Department of Hematology, ASST Spedali Civili di Brescia
Department of Hematology, ASST Spedali Civili di Brescia
Vol. 105 No. 5 (2020): May, 2020 https://doi.org/10.3324/haematol.2019.223891